Cordelia Pharmaceutical Private Limited
About Cordelia Pharmaceutical Private Limited
Data last updated:
Cordelia Pharmaceutical Private Limited was a private limited company based in New Delhi, Delhi, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 23 February 2015.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U51101DL2015PTC277079. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors including Rabindra Kumar Verma and Shushant Kumar.
Its last annual general meeting (AGM) was held on 30 September 2017, and its latest financial statements are for the year ended 31 March 2017. The registered office was at B14 Jawahar Mohalla Lane No 10 Shashi Garden Mayur Vihar Phase I, New Delhi, Delhi, India – 110091.
As per the financials filed for FY 2017, the company reported a revenue of ₹3.01 Lakh. For the same year it recorded a net loss of ₹27,700 (net margin -9.2%) and EBITDA of -₹26,270 (EBITDA margin -8.7%).
Company details
Contact details
Cordelia Pharmaceutical Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressB14 Jawahar Mohalla Lane No 10 Shashi Garden Mayur Vihar Phase I, New Delhi, Delhi, India – 110091
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Cordelia Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Cordelia Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Cordelia Pharmaceutical Private Limited, buy the company report.
Financials of Cordelia Pharmaceutical Private Limited
FY 2017 filings availableCordelia Pharmaceutical Private Limited reported revenue of ₹3.01 Lakh for FY 2017.
Financial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | ₹3.01 Lakh | ||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹26,270 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹27,700 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -8.7% | ||
| Net Profit Margin | -9.2% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Cordelia Pharmaceutical Private Limited, buy the company report.
Board of directors of Cordelia Pharmaceutical Private Limited
Cordelia Pharmaceutical has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rabindra Kumar Verma | Director | 06 Nov 2017 | 8 Years 11 Months | As last reported |
| Shushant Kumar | Director | 23 Feb 2015 | 11 Years 8 Months | As last reported |
| Sonal Anil Jeswal | Director | 23 Feb 2015 | 11 Years 8 Months | As last reported |
Peer comparison
Cordelia Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Emersyn Naturals Private Limited | ₹3.03 Lakh (FY 2024) | -70.0% | Palghar, Maharashtra, India | |||
| Zayanova Health Care Private Limited | ₹3.03 Lakh (FY 2024) | 635.0% | Guwahati, Assam, India | |||
| New Lifescience Private Limited | ₹3.02 Lakh (FY 2022) | Chennai, Tamil Nadu, India | ||||
| Arvn Nutrition (OPC) Private Limited | ₹3.02 Lakh (FY 2025) | -4.0% | New Delhi, Delhi, India | |||
| Refractx Private Limited | ₹3.01 Lakh (FY 2024) | -14.0% | Chennai, Tamil Nadu, India | |||
| Cordelia Pharmaceutical Private Limitedthis company | ₹3.01 Lakh (FY 2017) | -₹27,700 | -9.2% | New Delhi, Delhi, India | ||
| Ananta Drugs and Pharmaceuticals Private Limited | ₹3 Lakh (FY 2025) | -31.0% | Sri Ganganagar, Rajasthan, India | |||
| Uni Am Private Limited | ₹3 Lakh (FY 2025) | -50.0% | Siliguri, West Bengal, India | |||
| Varvee Herbs Private Limited | ₹3 Lakh (FY 2018) | -45.0% | Visakhapatnam, Andhra Pradesh, India | |||
| Kelvin Pharmaceutical Laboratories Pvt Ltd | ₹3 Lakh (FY 2025) | 2.0% | Cuttack, Odisha, India | |||
| Diamond Chlorides Private Limited | ₹3 Lakh (FY 2025) | -91.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Cordelia Pharmaceutical Private Limited, buy the company report.
Auditor
Cordelia Pharmaceutical Private Limited is audited by S Seth & Associates for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S Seth & Associates | FY 2017 | 086979 |
Shareholding
The shareholding of Cordelia Pharmaceutical Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Cordelia Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Cordelia Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cordelia Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Cordelia Pharmaceutical has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Cordelia Pharmaceutical Private Limited, buy the company report.
Recent activity
Cordelia Pharmaceutical Private Limited has 5 board changes on record since 2015: 3 appointments and 2 cessations. The latest: Rabindra Kumar Verma was appointed as Director on 06 Nov 2017.
Frequently asked questions
Cordelia Pharmaceutical has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Cordelia Pharmaceutical was a private limited company based in New Delhi, Delhi, India. The company worked in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 23 February 2015 and is registered under CIN U51101DL2015PTC277079. The company has been struck off by the Registrar of Companies and is no longer operational.
Cordelia Pharmaceutical had 3 directors:
- Rabindra Kumar Verma - Director
- Shushant Kumar - Director
- Sonal Anil Jeswal - Director
The CIN (Corporate Identification Number) of Cordelia Pharmaceutical is U51101DL2015PTC277079. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Cordelia Pharmaceutical is at B14 Jawahar Mohalla Lane No 10 Shashi Garden Mayur Vihar Phase I, New Delhi, Delhi, India – 110091.
Cordelia Pharmaceutical was incorporated on 23 February 2015. It is registered with the Registrar of Companies, Delhi.
The latest financial statements of Cordelia Pharmaceutical on record with the MCA are for the year ended 31 March 2017. Its last annual general meeting was held on 30 September 2017. Year-wise statements from 2015 are in the company report.
No. Cordelia Pharmaceutical has 1 GST registration on record and it is cancelled or inactive.
Cordelia Pharmaceutical operated in the pharma industry, in the pharmaceutical retailers and distributors segment. It worked in this industry before it was struck off.
The peers of Cordelia Pharmaceutical by revenue are Emersyn Naturals Private Limited, Zayanova Health Care Private Limited, New Lifescience Private Limited, Arvn Nutrition (OPC) Private Limited, Refractx Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Rabindra Kumar Verma was appointed as Director on 06 Nov 2017. Firdousi ceased to be Director on 04 Feb 2016. Firdousi ceased to be Director on 04 Feb 2016. Cordelia Pharmaceutical has 5 board changes on record in total.